Summary & Overview
CPT 42831: Initial Adenoidectomy for Patients Aged 12 Years or Older
CPT code 42831 identifies an initial adenoidectomy for patients aged 12 years and older, an ENT surgical procedure commonly performed in hospital outpatient departments and ambulatory surgery centers. Nationally, adenoidectomy coding affects surgical utilization metrics, payer coverage determinations, and facility billing practices for adolescent and adult patients undergoing upper airway surgery. Accurate use of this CPT code is important for clinical reporting, reimbursement alignment, and claims processing.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of expected sites of service, common modifiers applicable to surgical procedures, and the clinical context for when an initial adenoidectomy is reported for patients aged 12 and older. The publication summarizes benchmark considerations, prevalent billing practices across major payers, and policy-related factors that influence coverage and medical necessity review nationally.
This report is intended to inform coding professionals, practice managers, and policy analysts about the clinical definition of the code, payer coverage scope, and the operational implications for facility and professional billing. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 42831 describes an initial adenoidectomy performed in a patient aged 12 years or older. This procedure involves surgical removal of the adenoids and is categorized as an ear, nose, and throat (ENT) surgical service.
-
Service type: Surgical procedure
-
Typical site of service: Hospital outpatient department or ambulatory surgery center
Clinical & Coding Specifications
Clinical Context
A typical patient is a 14-year-old adolescent presenting to an otolaryngology clinic with a 12–18 month history of nasal obstruction, snoring, and recurrent otitis media with effusion refractory to medical therapy. Symptoms include chronic mouth-breathing, sleep-disordered breathing with witnessed apnea episodes, and persistent conductive hearing loss from middle-ear effusion. Examination and flexible nasopharyngoscopy demonstrate enlarged adenoids obstructing the nasopharyngeal airway. Audiometry and tympanometry confirm middle-ear effusion. After failed conservative management (nasal steroid trial, observation, antibiotic courses when indicated), the otolaryngologist schedules an operative adenoidectomy. The procedure is performed in an ambulatory surgical center or hospital outpatient surgical suite under general anesthesia with endotracheal intubation. Intraoperative steps include visualization of the nasopharynx, removal of adenoid tissue with curette or microdebrider, hemostasis, and inspection for residual tissue. If concurrent procedures (for example, myringotomy with tube placement) are indicated, they may be performed during the same anesthesia encounter. Postoperative recovery includes short observation in PACU with discharge instructions for analgesia and activity restrictions and follow-up for symptom resolution and hearing reassessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit documents evaluation beyond preop/decision making on the day of adenoidectomy |